UCSF

ZINC18189761

Substance Information

In ZINC since Heavy atoms Benign functionality
October 3rd, 2008 18 No

Other Names:

( inverted question mark)-N-Cyano-N'-4-pyridinyl-N''-(1,2,2-trimethylpropyl)-guanidine

(+-)-2-Cyano-1-(4-pyridyl)-3-(1,2,2-trimethylpropyl)guanidine monohydrate; C13H19N5; Guanidine, N''-cyano-N-4-pyridinyl-N'-(1,2,2-trimethylpropyl)-, monohydrate, (+-)-; Guanidine, N''-cyano-N-4-pyridinyl-N'-(1,2,2-trimethylpropylmonohydrate), (+-)-; Guani

(+-)-Pinacidil

(+-)-Pinacidil; (R,S)-Pinacidil; 2-Cyano-3-(4-pyridinyl)-1-(1,2,2-trimethylpropyl)guanidine; 2-Cyano-3-(4-pyridyl)-1-(1,2,2-trimethylpropyl)guanidine monohydrate; C13H19N5; EINECS 262-294-9; Guanidine, 2-cyano-3-(4-pyridyl)-1-(1,2,2-trimethylpropyl)-, mon

(+/-)-N-Cyano-N'-4-pyridinyl-N"-(1,2,2-trimethylpropyl)guanidine

(R,S)-Pinacidil

dil

1-cyano-2-(3,3-dimethylbutan-2-yl)-3-pyridin-4-ylguanidine

113563-69-2

2-Cyano-3-(4-pyridinyl)-1-(1,2,2-trimethylpropyl)guanidine

2-Cyano-3-(4-pyridyl)-1-(1,2,2-trimethylpropyl)guanidine monohydrate

60560-33-0

85371-64-8

85371-64-8 (Parent)

85371-64-8; C13729; Pinacidil

85371-64-8; D05482; Pinacidil (USAN); Pinacidil hydrate; Pindac (TN)

85371-64-8; Prestwick_396; pinacidil

AC1L1J1H

AC1Q4SLP

AKOS001637331

AR-1C2481

BCBcMAP01_000050

Bio1_000164

Bio1_000653

Bio1_001142

Bio2_000181

Bio2_000661

BPBio1_000036

BRD-A43882281-001-06-4

BRD-A58207013-001-01-2

BSPBio_000032

BSPBio_001461

BSPBio_002360

C13H19N5

CBiol_001878

CHEBI:287515

CHEMBL1159

CID4826

CPD000466919; Pinacidil monohydrate

CPD000466919; Pinacidil monohydrate; SAM001246907

CPD000466919; Pinacidil; Pinacidil monohydrate; SAM001246907

DAP001417

DivK1c_006855

EINECS 262-294-9

EU-0101037

FDA

FDA)

Guanidine, 2-cyano-3-(4-pyridyl)-1-(1,2,2-trimethylpropyl)-, monohydrate

Guanidine, N-cyano-N'-4-pyridinyl-N''-(1,2,2-trimethylpropyl)-

Guanidine, N-cyano-N'-4-pyridinyl-N''-(1,2,2-trimethylpropyl)-, monohydrate

HMS1361J03

HMS1568B14

HMS1791J03

HMS1922L10

HMS1989J03

HMS2089C19

HMS2094G21

IDI1_033931

INN

KBio1_001799

KBio2_000181

KBio2_000867

KBio2_002749

KBio2_003435

KBio2_005317

KBio2_006003

KBio3_000361

KBio3_000362

KBioGR_000181

KBioSS_000181

KBioSS_000867

LS-73486

MFCD00153861

MFCD00242745

MLS000069377

MLS002154248

MolPort-003-666-777

N-Cyano-N'-4-pyridinyl-N''-(1,2,2-trimethylpropyl)guanidine

NCGC00025188-02

NCGC00025188-03

NCGC00025188-04

NCGC00025188-05

NCGC00025188-06

NCGC00025188-07

NCGC00025188-08

NCGC00095199-01

NCGC00095199-02

NCGC00095199-03

NCGC00095199-04

P 1134

P-1134

P-154

P154_SIGMA

Pinacidil (anhydrous)

Pinacidil (FDA

Pinacidil (INN

Pinacidil hydrate

Pinacidil monohydrate

Pinacidilmonohydrate

Pinacidilum

Pinacidilum [INN-Latin]

PINDAC

Prestwick0_000246

Prestwick1_000246

Prestwick2_000246

Prestwick3_000246

Prestwick_396

QA-1331

S 1230

S-1230

Seratrodast

SMR000058360

SPBio_001818

SPBio_002251

SpecPlus_000759

SPECTRUM2300270

Spectrum2_001739

Spectrum5_001372

Spectrum_000387

USAN

USAN)

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 2.18 9.68 -19.84 2 5 0 76 245.33 4
Ref Reference (pH 7) 2.18 8.8 -19.26 2 5 0 76 245.33 4
Ref Reference (pH 7) 2.01 8.02 -6.12 2 5 0 73 245.33 5
Ref Reference (pH 7) 2.01 10.47 -5.37 2 5 0 73 245.33 5
Hi High (pH 8-9.5) 2.18 8.31 -33.34 1 5 -1 75 244.322 4
Hi High (pH 8-9.5) 2.01 10.06 -33.2 1 5 -1 75 244.322 5
Hi High (pH 8-9.5) 2.18 9.19 -29.92 1 5 -1 75 244.322 4
Hi High (pH 8-9.5) 2.01 10.09 -30.29 1 5 -1 75 244.322 5
Mid Mid (pH 6-8) 2.01 10.22 -9.07 2 5 0 73 245.33 5
Mid Mid (pH 6-8) 2.01 8.58 -4.5 2 5 0 73 245.33 5
Lo Low (pH 4.5-6) 2.01 8.47 -33.8 3 5 1 74 246.338 5
Lo Low (pH 4.5-6) 2.01 10.7 -36.72 3 5 1 74 246.338 5
Lo Low (pH 4.5-6) 2.01 10.93 -33.34 3 5 1 74 246.338 5
Lo Low (pH 4.5-6) 2.01 9.05 -33.93 3 5 1 74 246.338 5

Vendor Notes

Note Type Comments Provided By
therap K channel agonist, antihypertensive MicroSource Spectrum
Therapy K+ channel activator; antihypertensive SMDC Pharmakon
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sigma Chemical Company; NCC_SUPPLIER_STRUCTURE_ID : P154; 1 water NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sigma Chemical Company; SUPPLIER_STRUCTURE_ID: P154; SALT: 1 water NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
ABCC9-2-E Sulfonylurea Receptor 2 (cluster #2 Of 2), Eukaryotic Eukaryotes 3540 0.42 Binding ≤ 10μM
IRK11-2-E Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11 (cluster #2 Of 2), Eukaryotic Eukaryotes 320 0.51 Binding ≤ 10μM
Z102306-1-O Aorta (cluster #1 Of 6), Other Other 350 0.50 Functional ≤ 10μM
Z50512-3-O Cavia Porcellus (cluster #3 Of 7), Other Other 9200 0.39 Functional ≤ 10μM
Z50597-3-O Rattus Norvegicus (cluster #3 Of 12), Other Other 800 0.47 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
IRK11_HUMAN Q14654 Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11, Human 320 0.51 Binding ≤ 1μM
ABCC9_HUMAN O60706 Sulfonylurea Receptor 2, Human 320 0.51 Binding ≤ 1μM
IRK11_HUMAN Q14654 Potassium Channel, Inwardly Rectifying, Subfamily J, Member 11, Human 320 0.51 Binding ≤ 10μM
ABCC9_HUMAN O60706 Sulfonylurea Receptor 2, Human 320 0.51 Binding ≤ 10μM
Z102306 Z102306 Aorta 350 0.50 Functional ≤ 10μM
Z50512 Z50512 Cavia Porcellus 3630 0.42 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 1500 0.45 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
ABC-family proteins mediated transport
ATP sensitive Potassium channels
Regulation of insulin secretion

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.